Travoprost

Products Travoprost is commercially available in the form of eye drops as a monopreparation (Travatan) and as a fixed combination with the beta-blocker timolol (Duotrav). It was approved in many countries in 2002. Generic versions were first released in 2016 and went on sale in 2017. Structure and properties Travoprost (C26H35F3O6, Mr = 500.55 g/mol) … Travoprost

Tafluprost

Products Tafluprost is available in the form of eye drops (saflutane). It was approved in many countries in 2010. In 2016, a fixed combination with timolol was also registered (Taptiqom). Structure and properties Tafluprost (C25H34F2O5, Mr = 452.53 g/mol) is a fluorinated analog of prostaglandin F2α (Figure). It is a prodrug and is converted at … Tafluprost

Latanoprost

Products Latanoprost is commercially available as eye drops in dropper bottles and as monodoses (Xalatan, generic, auto-generic, 50 µg/ml). It is also available as a fixed combination with timolol (Xalacom, generic, auto-generic). Latanoprost was developed in the 1980s as part of a collaboration between Columbia University in New York and Pharmacia in Uppsala, Sweden (Stjernschantz, … Latanoprost

Bimatoprost

Products Bimatoprost is commercially available in the form of eye drops (Lumigan). It is also available in combination with timolol (Ganfort, Ganfort UD). The drug was approved in many countries in 2002. Generics are registered. Latisse (0.3 mg/ml) to promote eyelash growth is on the market in the United States. Structure and properties Bimatoprost (C25H37NO4, … Bimatoprost